U.S. sales of RSV vaccines from GSK and Pfizer are down significantly after regulators narrowed the targeted age group and ...

(Reuters) - U.S. sales of RSV vaccines from GSK and Pfizer are down significantly after regulators narrowed the targeted age ...

Pfizer on Monday won a bid in a London court to invalidate two of GSK's patents relating to a respiratory syncytial virus ...

GSK presents positive data for AREXVY, its respiratory syncytial virus (RSV) vaccine, indicating protection over three RSV ...

The Alberta government announced Monday that the RSV vaccine, Abyrsvo, will be provincially funded for Albertans, aged 60 and ...

As the days grow cooler, families across Utah are reminded that respiratory viruses, particularly Respiratory Syncytial Virus ...

Low uptake in the RSV and COVID vaccine markets is not surprising, an analyst says, and could mean weak earnings for ...

RSV vaccination was associated with decreased risks for infection and hospitalization, although the decrease was not statistically significant.

GSK announced on Tuesday that a single dose of its Arexvy vaccine against respiratory syncytial virus (RSV) was 43.3% ...

In most cases, adequate hydration and over-the-counter pain relievers can help manage your symptoms during the week or two it ...

The RSV vaccine is unequivocally recommended for adults who are residents in skilled nursing and assisted living facilities.

The vaccine demonstrated efficacy across different respiratory syncytial virus (RSV) subtypes in older adults between the ...